Modular Access to Azepines by Directed Carbonylative C-C Bond Activation of Aminocyclopropanes by Wang, Gangwei & Bower, John
                          Wang, G., & Bower, J. (2018). Modular Access to Azepines by Directed
Carbonylative C-C Bond Activation of Aminocyclopropanes. Journal of the
American Chemical Society, 140(8), 2743-2747.
https://doi.org/10.1021/jacs.7b13087
Publisher's PDF, also known as Version of record
License (if available):
CC BY
Link to published version (if available):
10.1021/jacs.7b13087
Link to publication record in Explore Bristol Research
PDF-document
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms
Modular Access to Azepines by Directed Carbonylative C−C Bond
Activation of Aminocyclopropanes
Gang-Wei Wang and John F. Bower*
School of Chemistry, University of Bristol, Bristol, BS8 1TS, United Kingdom
*S Supporting Information
ABSTRACT: A modular Rh-catalyzed entry to azepines is
outlined. Under a CO atmosphere, protecting group
directed C−C bond activation of aminocyclopropanes
provides rhodacyclopentanones. These intermediates are
eﬀective for intramolecular C−H metalation of either an
N-aryl or N-vinyl unit en route to azepine ring systems.
Thus, byproduct-free heterocyclizations are enabled by
sequential C−C activation and C−H functionalization
steps.
The azepine ring system is present in a wide range ofbioactive compounds, with this motif or closely related
variants representing the core structure of over 25 pharma-
ceutical products.1 For example, the drugs Tolvaptan2 and
Benazepril,3 and the beef improvement agent Zilpaterol,4 all
contain the tetrahydrobenzo[b]azepine ring system (Scheme
1A). Despite their established pharmaceutical value, azepines
and other larger (>6-membered) N-heterocyclic rings are
underrepresented in drug discovery libraries,5 primarily because
of a lack of eﬃcient and modular routes for their preparation.
Accordingly, synthetic methods that can address this issue are
in high demand.
Recently, as part of a broader program,6 we outlined an N-
heterocyclization strategy where “capture” of transient
rhodacyclopentanones 2 by tethered nucleophiles occurs in
advance of a C−Nu bond forming “collapse” to the targets
(Scheme 1B).6e Conceptually, this approach is appealing
because it harnesses the strain embodied within readily
available and stereodeﬁned aminocyclopropanes 1 for reaction
initiation, and achieves otherwise challenging ring closures via
the intermediacy of kinetically accessible bicycles 3. In our
proof-of-concept studies, ureas were used as the nucleophile (1,
R3 = NHR), such that intermediates 2 were converted to 1,3-
diazepanes by C−N reductive elimination from 3.6e Outside of
π-insertion processes, the reactivity of rhodacyclopentanones is
relatively unexplored,7−9 rendering further extension of our
approach uncertain. However, it is well-established that
Rh(III)-complexes can promote aryl C−H metalation in
other contexts,10 and we considered whether this type of
process might be exploited from 2 to provide benzazepines 6.
Speciﬁcally, for cyclopropanes 1 where R2 = aryl, we envisaged
accessing targets 6 by a sequence of carbonyl directed C−C
oxidative addition, metallacyclobutane carbonylation (to 2),
aryl C−H metalation (to 5), C−C reductive elimination, and
protodemetalation. At the outset, the viability of this design was
considered tentative because of the absence of reports where
rhodacyclopentanones engage in C(sp2)−H metalation or
C(sp2)−C(sp2) reductive elimination processes. Nevertheless,
outlined below is the successful realization of this approach,
which provides striking examples of how metal-catalyzed
carbonylative redistribution of C−C and C−H bonds can be
harnessed in reaction design.
Our investigations commenced by exploring the carbon-
ylative cyclization of 1a, which was readily prepared in two
steps via N-arylation of cyclopropylamine and subsequent Cbz-
protection (see the Supporting Information (SI)). Here we
found that, using 1 atm CO, the combination of [Rh(cod)2]-
OTf (7.5 mol %), P(4-CF3C6H4)3 (15 mol %), Na2SO4 (30
mol %), and 2-NO2C6H4CO2H (100 mol %) enabled the
generation of 6a in 82% isolated yield. Notably, neutral Rh-
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precatalysts were completely ineﬀective and electron-neutral/-
rich P-based ligands provided only traces of the product (see
the SI). 6a was formed in less than 30% yield in the absence of
2-NO2C6H4CO2H, with this additive likely acting as a proton
reservoir to facilitate the ﬁnal protodemetalation step, which
otherwise would rely solely on the proton released during the
conversion of 2 to 5.
With optimized conditions in hand, we explored the scope of
the process with respect to the aromatic unit (Table 1). A
broad range of arenes are tolerated, with electron-rich (e.g., 1f),
electron-poor (e.g., 1d), and heteroaromatic systems (e.g., 1j)
all participating with similar levels of eﬃciency. For systems
with meta-substituents (1g and 1i), C−C bond formation is
highly regioselective, occurring at the more sterically accessible
ortho-position. In the case of 1h, where both meta-positions are
substituted, cyclization to 6h could be achieved, but the yield of
the process was lower than for other examples. At the present
stage, the protocol does not tolerate acyclic ortho-substituents.
The method exhibits useful levels of ﬂexibility with respect to
the directing group. For example, other classes of carbamate
can be used, as demonstrated by Fmoc-directed cyclization of
1b which provided 6b in 79% yield. Cyclic amides can also
direct the process, and this allowed access to tricyclic systems
6k and 6l in 66% and 62% yield, respectively. However, acyclic
amides and N-urea-based directing groups are ineﬀective (see
the SI), highlighting the ﬁnely balanced nature of the process,
where the DG must be Lewis basic enough to promote C−C
bond activation, but also suﬃciently labile to allow aryl C−H
metalation (2 to 5).11
At this stage, a series of experiments was undertaken to probe
the mechanism of the process, and this insight proved
fundamental in guiding extensions of the approach outlined
later (Scheme 2). When a 1:1 mixture of 1f and 1c was exposed
to standard conditions, an approximately equimolar ratio of 6f
and 6c was obtained at low conversion (eq 1). A similar
competition experiment involving a 1:1 mixture of 1a and
deuterio-1a revealed a relatively small kinetic isotope eﬀect (kH/
kD = 1.44, eq 2).
12 Taken together, these experiments suggest
that aryl C−H metalation is not turnover limiting. Further
insight was gained by running the carbonylative cyclization of
1a in the presence of CD3OD (300 mol %). At full conversion
(eq 3), deuterium incorporation in the product deuterio-6a′ was
observed at C-2 (12%), C-4 (23%), C-6 (9%), and C-9 (15%).
Deuteration at C-2 is consistent with protodemetalation at this
position (to 6) after C−C reductive elimination from 5. At
partial conversion (eq 4), lower levels of C-6 deuteration were
observed (deuterio-6a″), which is consistent with exchange at
this position occurring via ketone directed C−H activation of
the product. In support of this, exposure of product 6a to
standard catalytic conditions in the presence of CD3OD
resulted in 12% deuterium incorporation at C6 (eq 5). In this
experiment, signiﬁcant exchange also occurred at C-4 (28%),
suggesting that deuterium incorporation observed at this
position in eqs 3 and 4 arises via enolization of the product.
Table 1. Scope of the Aromatic Component
aReaction carried out at 140 °C.
Scheme 2. Mechanistic Experiments
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Accordingly, the key issue remains as to how deuterium
incorporation at C-9 of deuterio-6a′/6a″ occurs? Equation 5
indicates that this is not via C−H activation of the product 6a.
Analysis of recovered starting material in eq 4 revealed
approximately 15% deuterium incorporation at the ortho-
positions (deuterio-1a′); however, a similar exchange experi-
ment involving 7, which lacks a cyclopropyl unit, resulted in no
deuterium incorporation at the ortho-positions (eq 6). This
seemingly rules out an exchange pathway involving carbonyl
directed C−H activation of 1a. Overall, the collective
observations provided in eqs 3−6 indicate that deuterium
exchange at C-9 of deuterio-6a′/6a″ and at the ortho-C−H
bonds of deuterio-1a′ does not occur directly from 1a or 6a, but
instead via reversible formation of another catalytically
generated intermediate, which is most likely bicycle 5.13
Indeed, our previous studies have shown that rhodacyclopenta-
none formation (1 to 2) is highly reversible using cationic Rh-
systems,6b,c,e and the current experiments extend this
reversibility to the aryl C−H metalation step. Accordingly, for
the current process, we favor C−C reductive elimination as the
ﬁrst irreversible step, and further evidence supporting this
assertion is given later.14
Substituted aminocyclopropanes can be accessed by Curtius
rearrangement of cyclopropyl carboxylic acids, and these, in
turn, can be synthesized easily in enantioenriched form.15
Consequently, the reaction design outlined in Scheme 1B
potentially allows access to benzazepines bearing stereodeﬁned
substituents that might be challenging to install using
conventional methods. Key requirements for 1,2-disubstituted
cyclopropane-based processes include (a) regioselective gen-
eration of the rhodacyclopentanone intermediate (2) and (b)
transfer of this regiochemistry to the product (vide infra).
Previous studies have revealed that directed rhodacyclo-
pentanone formation from trans-1,2-disubstituted cyclopro-
panes occurs with high selectivity via the less hindered proximal
C−C bond (bond a in 1m−o, Scheme 3A).6c However, as
outlined above, the formation of 2 is likely reversible, such that
product regiochemistry can be subject to Curtin−Hammett
selectivity.16 Indeed, initial attempts to access benzazepine 6m
(R = Me) using the conditions from Table 1 aﬀorded
approximately equal ratios of C-3 and C-4 adducts 6m and
6m′. The former arises from the kinetically favored rhodacyclo-
pentanone 5m; however, subsequent C−C reductive elimi-
nation is likely to be slow because it requires the bulky Rh-
center to move into the proximity of the C-3 methyl
substituent. As such, reversible metallacycle formation provides
kinetically disfavored regioisomer 5m′, which undergoes more
facile C−C reductive elimination to provide C-4 methylated
regioisomer 6m′. Electron-deﬁcient ligand systems are known
to accelerate C−C reductive elimination,17 and so we examined
whether replacement of P(4-CF3C6H4)3 with poorer donors
might enforce selective generation of 6m from 1m (Scheme
3B). These studies revealed that 6m could be generated with
essentially complete selectivity over 6m′ using either As(4-
CNC6H4)3 or P(C6F5)3 as ligand. The latter oﬀered the greatest
eﬃciencies with 6m isolated in 68% yield and >99:1 e.r. from
enantiopure 1m. These new conditions extended to more
sterically demanding systems 1n and 1o, which cyclized to
provide 6n and 6o as single regioisomers in 52% and 67% yield,
respectively (Scheme 3C); 6o was prepared from racemic 1o,
whereas 6n (99:1 e.r.) was accessed from enantioenriched 1n
(99:1 e.r.). For the processes in Scheme 3C, 3-CNC6H4CO2H
oﬀered higher eﬃciencies than 2-NO2C6H4CO2H, which was
used earlier (see Table 1). So far, we have been unable to
obtain high selectivity for the formation of C-4 substituted
products (6m′−o′); however, substitution at this position can
be introduced easily using enolate chemistry.18 For example,
highly diastereoselective conversion of 6m to α-functionalized
products 8a and 8b was readily achieved, which demonstrates
the feasibility of introducing C−C or C−heteroatom bonds at
C-4.
The heterocyclizations described so far use an N-aryl unit as
the nucleophilic component, and we questioned whether
further classes of process might be achieved using other types
of π-nucleophile. Speciﬁcally, we hoped to access non-
benzofused azepines (6p−t) by harnessing N-vinyl nucleo-
philes (1p−t) (Table 2). In the event, by adapting of our
previously developed conditions, carbonylative heterocycliza-
tion of 1p to 6p and 1q to 6q occurred in 61% yield and 42%
yield, respectively. Here, the carboxylic acid additive was
omitted as it promoted competitive polymerization of 1p and
1q. However, for subsequent examples (6r−t), an acid additive
was beneﬁcial, with the exact choice made on a case-by-case
basis. A key aspect of the method in Table 2 is that the
substrates (1p−t) can be accessed in one pot from the
corresponding ketone (see the SI), which, in turn, allows the
two-step synthesis of a wide variety of interesting and
challenging heterocyclic ring systems. From a mechanistic
viewpoint, these processes are signiﬁcant; in principle, the
Scheme 3. Benzazepines via trans-1,2-Disubstituted
Cyclopropanes
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carboxylic acid additive could facilitate CMD-type metalation of
the C(sp2)−H bond (2 to 5),19 but the successful synthesis of
6p and 6q in the absence of acid suggests that this is not the
case. Accordingly, we suggest that, for both N-aryl and N-vinyl
systems, C−H metalation occurs by nucleophilic attack of the
electron-rich π-system onto the Rh-center of 2, and that the
primary role of the acid additive is to facilitate the ﬁnal
protodemetalation step.
To conclude, we outline processes where rhodacyclo-
pentanones generated by directed carbonylative C−C bond
activation are captured by C-based nucleophiles en route to
benzazepines and nonbenzofused variants. Ring systems of this
type are diﬃcult to construct in a modular fashion using
conventional approaches,20 and the methodology addresses this
issue in an atom and step economical manner. Our reaction
design is based on the exploitation of rhodacyclopentanones for
C(sp2)−H metalation and subsequent C(sp2)−C(sp2) bond
forming reductive elimination.9,14 One can easily envisage
harnessing these fundamental mechanistic steps in further
rhodacyclopentanone-based methodologies. Studies toward this
broad goal are ongoing and will be reported in due course.
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